SG Americas Securities’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,462
| Closed | -$22K | – | 2633 |
|
|
2024
Q1 | $22K | Sell |
2,462
-1,933
| -44% | -$17.3K | ﹤0.01% | 2496 |
|
|
2023
Q4 | $42K | Buy |
4,395
+1,111
| +34% | +$10.6K | ﹤0.01% | 2660 |
|
|
2023
Q3 | $39K | Buy |
+3,284
| New | +$39K | ﹤0.01% | 2671 |
|
|
2023
Q2 | – | Sell |
-2,134
| Closed | -$67K | – | 2404 |
|
|
2023
Q1 | $67K | Buy |
2,134
+218
| +11% | +$6.84K | ﹤0.01% | 2750 |
|
|
2022
Q4 | $135K | Buy |
1,916
+146
| +8% | +$10.3K | ﹤0.01% | 2276 |
|
|
2022
Q3 | $152K | Sell |
1,770
-47
| -3% | -$4.04K | ﹤0.01% | 2266 |
|
|
2022
Q2 | $150K | Buy |
1,817
+1,045
| +135% | +$86.3K | ﹤0.01% | 2614 |
|
|
2022
Q1 | $128K | Sell |
772
-26,989
| -97% | -$4.47M | ﹤0.01% | 2373 |
|
|
2021
Q4 | $4.64M | Buy |
27,761
+25,413
| +1,082% | +$4.25M | 0.03% | 472 |
|
|
2021
Q3 | $203K | Buy |
+2,348
| New | +$203K | ﹤0.01% | 2969 |
|
|
2020
Q3 | – | Sell |
-1,420
| Closed | -$74K | – | 2550 |
|
|
2020
Q2 | $74K | Buy |
1,420
+341
| +32% | +$17.8K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $47K | Buy |
+1,079
| New | +$47K | ﹤0.01% | 2696 |
|